EVOS seeks $10 million to boost EV charger manufacture


Electric vehicle charger manufacturer and fleet management specialist EVOS Energy is seeking an additional $6 million from investors, having already completed a $4 million raise from existing investors.

The latest $10 million funding round, once completed, will fuel growth in the company’s sales and marketing teams selling their locally designed and manufactured EV chargers.

The raise, which comes a year after a $5 million raising, will also enable the company to expand its manufacturing and bring products to market faster.

CEO Marcelo Salgado said: “We’re ramping up the rollout of new products and software rapidly, and demand for EV charging at home is only increasing from here on out.

“Sales of EVs are up more than 30 per cent over the same period last year and that number will increase as OEMs move further away from petrol-powered to zero emissions vehicle manufacturing.

“Research shows that EV owners will spend most of their charging time at home or the workplace – and we know that Australians are keen on Australian products.”

Earlier this year EVOS launched its Fleet Platform, and energy management solution for EV-ready business sites.

This complements its SB7 charger and Fleet Home 22 AC charger which can choose the ideal idle time for the charger to charge the vehicle, whether its overnight in non-peak periods or during business hours.

It can also control charge rate, speed and power to ensure owners can manage their energy output, thus reducing the costs of charging.

Chief Technology Officer Chris Crossman said: “What we’re trying to solve is not only the issue of charging, but the issue of energy.

“Managing and understanding energy consumption will be a challenge for fleet operators and private owners alike, but our ecosystem perfectly manages when to charge based on feed-in tariffs, when energy is cheapest and also when solar is involved.”

Further reading:
EVOS raises $5 million ahead of new charger release


Share this Story

Stay Informed

Go to Top